Search Results - "Samuel, Stephen P"
-
1
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
Published in Toxins (11-11-2022)“…The availability of effective, reliably accessible, and affordable treatments for snakebite envenoming is a critical and long unmet medical need. Recently,…”
Get full text
Journal Article -
2
Delayed LY333013 (Oral) and LY315920 (Intravenous) Reverse Severe Neurotoxicity and Rescue Juvenile Pigs from Lethal Doses of Micrurus fulvius (Eastern Coral Snake) Venom
Published in Toxins (17-11-2018)“…There is a clear, unmet need for effective, lightweight, shelf-stable and economical snakebite envenoming therapies that can be given rapidly after the time of…”
Get full text
Journal Article -
3
Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
Published in Journal of tropical medicine (01-01-2018)“…The World Health Organization (WHO) recently added snakebite envenoming to the priority list of Neglected Tropical Diseases (NTD). It is thought that ~75% of…”
Get full text
Journal Article -
4
The BRAVO Clinical Study Protocol: Oral Varespladib for Inhibition of Secretory Phospholipase A2 in the Treatment of Snakebite Envenoming
Published in Toxins (28-12-2022)“…Snakebite is an urgent, unmet global medical need causing significant morbidity and mortality worldwide. Varespladib is a potent inhibitor of venom secretory…”
Get full text
Journal Article -
5
Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom
Published in Toxins (20-09-2018)“…There is an unmet need for economical snakebite therapies with long shelf lives that are effective even with delays in treatment. The orally bioavailable,…”
Get full text
Journal Article -
6
-
7
Oral and IV Varespladib Rescue Experiments in Juvenile Pigs with Weakness Induced by Australian and Papuan Oxyuranus scutellatus Venoms
Published in Toxins (07-09-2023)“…Antivenom is currently the standard-of-care treatment for snakebite envenoming, but its efficacy is limited by treatment delays, availability, and in many…”
Get full text
Journal Article -
8
State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis?
Published in International journal of biological macromolecules (01-12-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent responsible for the Coronavirus Disease-2019 (COVID-19) pandemic, has…”
Get full text
Journal Article -
9
In vitro anticoagulant effects of Bungarus venoms on human plasma which are effectively neutralized by the PLA2-inhibitor varespladib
Published in Toxicon (Oxford) (13-11-2024)“…Bungarus (krait) envenomings are well-known for their life-threatening neurotoxic effects. However, their impact on coagulation remains largely unexplored…”
Get full text
Journal Article -
10
Early Treatment with Intranasal Neostigmine Reduces Mortality in a Mouse Model of "Naja Naja" (Indian Cobra) Envenomation
Published in Journal of Tropical Medicine (01-01-2014)“…Objective. Most snakebite deaths occur prior to hospital arrival; yet inexpensive, effective, and easy to administer out-of-hospital treatments do not exist…”
Get full text
Journal Article -
11
Snakebite: An Exploratory Cost-Effectiveness Analysis of Adjunct Treatment Strategies
Published in The American journal of tropical medicine and hygiene (01-01-2018)“…The cost-effectiveness of the standard of care for snakebite treatment, antivenom, and supportive care has been established in various settings. In this study,…”
Get full text
Journal Article -
12
CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility
Published in International journal of nanomedicine (01-01-2015)“…New nanomaterials intended for systemic administration have raised concerns regarding their biocompatibility and hemocompatibility. Quantum dots (QD)…”
Get full text
Journal Article -
13
Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trial
Published in BMJ global health (22-10-2024)“…Snakebite envenoming (SBE) results in over 500 000 deaths or disabling injuries annually. Varespladib methyl, an oral inhibitor of secretory phospholipase A2,…”
Get full text
Journal Article -
14
Parotid swelling after Russell's viper envenomation: an unusual and poor prognostic sign
Published in Clinical case reports (01-02-2018)“…Key Clinical Message Parotid swelling, an unusual and poorly understood sign, is associated with poor prognosis in the setting of Russell's viper envenomation…”
Get full text
Journal Article -
15
Oral and IV Varespladib Rescue Experiments in Juvenile Pigs with Weakness Induced by Australian and Papuan IOxyuranus scutellatus/I Venoms
Published in Toxins (01-09-2023)“…Antivenom is currently the standard-of-care treatment for snakebite envenoming, but its efficacy is limited by treatment delays, availability, and in many…”
Get full text
Journal Article -
16
Early treatment with intranasal neostigmine reduces mortality in a mouse model of Naja naja
Published in Journal of tropical medicine (01-01-2014)“…Objective. Most snakebite deaths occur prior to hospital arrival; yet inexpensive, effective, and easy to administer out-of-hospital treatments do not exist…”
Get full text
Journal Article -
17
Parotid swelling after Russell's viper envenomation: an unusual and poor prognostic sign
Published in Clinical case reports (01-02-2018)Get full text
Report